WeChat Share

The 8th DIA China Annual Meeting

<span style="font-size: 16px;"><span style="font-family: arial,helvetica,sans-serif;"><span style="font-family: arial, helvetica, sans-serif; font-size: 16px;"><span style="font-family: arial, helvetica, sans-serif; font-size: 16px;">Untitled Document</span></span></span></span>


The 8th DIA China Annual Meeting 2016 “Quality and Transformation - the New Era of Drug Development" will feature over 70 sessions in 17 themes on cutting edge topics, including Innovative Partnerships, Patient Care, and the CFDA’s Regulatory Reform and its potential impact on quality and the drug development environment. This meeting is the largest interdisciplinary event in Asia. Professionals involved at all levels in the discovery, development, and life cycle management of health care products, will travel from China and around the world to share their viewpoints, knowledge, experience, and cross-functional content resulting in real-world application. Join us in Beijing for more highlights, preconference workshops, plenary forum, poster presentations, and exhibitions by over 100 global service and product providers, plus special community and networking opportunities.

Preliminary Themes Snapshot

  • CFDA Townhall
  • Special Forum – Enabling Key Capability for Innovation in China
  • Rapid Evolving China Regulatory Science – Seize the Opportunity for Driving Innovation
  • Develop Innovative Solution to Fill the Unmet Medical Needs in China – Special Focuses on Oncology, Diabetes, Cardiovascular and HCV/HBV
  • Operational Excellence – China’s Own Challenges and Unique Opportunity
  • Clinical Trial Sites in China – Bottleneck or the Anchor for Quality Clinical Trials
  • Quantitative Science – The Backbone of Evidence Based Data Generation
  • CMC & Generic Drug
  • Biologics & Biosimilar Development
  • Medical Affairs – MSLs, Marketing New Model Engagement, Compliance and Market Access
  • Key Elements in Successful Drug Activities – Medical Writing and Project Management
  • Safety Surveillance   
  • Pharmacovigilance
  • Quality System – from the Regulator, Investigator and Sponsor's Perspectives
  • Early Stage Drug Development – Toxicity, Translational Medicine, and Biomarker
  • CRO, SMO & Investigator
  • Information Technology
  • Hot Topics and Late Breaker – Medical Devices, Rare Diseases, CDx, and Genetic Material Collection 

Planned Pre-conference Workshops

  • Inspection Readiness
  • Medical Coding
  • Strategy and Key Considerations for Simultaneous Filing of Innovative Drugs in China and Abroad
  • CDISC Standard
  • How to Prepare New Product Launch - Medical Affairs Strategy and Tool Kits
  • MSLs Practice during New Product Launch
  • Aim at Drug Market - Preclinical and Clinical Documentation Strategy

    May 15, 2016: Pre-conference Workshops

    May 16-18, 2016: Conference, Exhibition and Posters

Contact Us

Your Name: *
Your Email: *
Cell phone:
Subject: *
Message: *

Date Time

2016-05-15 08:30 - Start

2016-05-18 17:30 - End

  • 中国 北京 朝阳区
  • 天辰东路7号 (No.7, Tianchen East Rd. Chaoyang Dist. Beijing | CNCC)